Indications for Torsemide in CKD Stages 3, 4, and 5
Primary Indications in CKD
- The American Heart Association recommends torsemide as a preferred loop diuretic in patients with moderate-to-severe CKD (GFR <30 mL/min) for the management of fluid overload and edema, particularly in heart failure patients 1
- Loop diuretics, including torsemide, are preferred over thiazide diuretics in patients with GFR <30 mL/min due to their maintained efficacy at lower GFR levels 1
- For patients with CKD and heart failure, torsemide is indicated at an initial dose of 10-20 mg once daily, with titration based on response 2
Dosing Considerations in CKD
- Torsemide has the advantage of once-daily dosing with a duration of action of 12-16 hours, compared to furosemide's 6-8 hour duration 2
Specific Clinical Scenarios
- For CKD patients with heart failure, torsemide is indicated as a loop diuretic of choice to improve symptoms of fluid retention 2
Advantages of Torsemide in CKD
- The extended duration of action (12-16 hours) of torsemide allows for once-daily dosing, which may improve medication adherence 2